Taro Pharmaceutical Indus Earnings Preview
Portfolio Pulse from Benzinga Insights
Taro Pharmaceutical Indus (NYSE:TARO) is set to release its latest quarterly earnings report on October 26, 2023. Analysts estimate an earnings per share (EPS) of $0.18. The company's past performance shows a beat in EPS last quarter, followed by a 0.11% increase in share price. The stock is currently trading at $33.5, with a 1.55% increase over the last 52-week period.
October 25, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Taro Pharmaceutical Indus is expected to report an EPS of $0.18 in its upcoming earnings. The company's stock price increased by 0.11% after beating EPS estimates last quarter.
The company's earnings report is a key event that could impact its stock price. If Taro Pharmaceutical Indus beats the EPS estimate, it could lead to a positive reaction in the stock price, as seen in the previous quarter. However, the impact could also depend on the company's guidance for the next quarter.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100